(旧版)女性下部尿路症状診療ガイドライン

 
3 疫学とQOL
参考文献
1) Kay L, Stigsby B, Brasso K, Mortensen SO, Munkgaard S. Lower urinary tract symptoms. A population survey using the Danish Prostatic Symptom Score(DAN-PSS)questionnaire. Scand J Urol Nephrol1 1999; 33: 94-99
2) Jackson S. Lower urinary tract symptoms and nocturia in men and women: prevalence, aetiology and diagnosis. BJU Int 1999; 84(Suppl 1): 5-8
3) van Dijk L, Kooij DG, Schellevis FG. Nocturia in the Dutch adult population. BJU Int 2002; 90: 644-648
4) Leppilahti M, Tammela TLJ, Huhtala H, Auvinen A. Prevalence of symptoms related to interstitial cystitis in women: a population based study in Finland. J Urol 2002; 168: 139-143
5) Boyle P, Robertson C, Mazzetta C, Keech M, Hobbs FDR, Fourcade R, Kiemeney L, Lee C and the UrEpik Study Group. The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study. BJU Int 2003; 92: 409-414
6) Nuotio M, Jylha M, Luukkaala T, Tammela TLJ. Health problems associated with lower urinary tract symptoms in older women. A population-based survey. Scand J Prim Health Care 2005; 23: 209-214
7) Nørby B, Nordling J, Mortensen S. Lower urinary tract symptoms in the Danish population: a populationbased study of symptom prevalence, health-care seeking behavior and prevalence of treatment in elderly males and females. Eur Urol 2005; 47: 817-823
8) Kupelian V, Wei JT, O’Leary MP, Kusek JW, Litman HJ, Link CL, McKinlay JB for the BACH Survey Investigators. Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample. The Boston Area Community Health(BACH)Survey. Arch Intern Med 2006; 166: 2381-2387
9) Elstad EA, Taubenberger SP, Botelho EM, Tennstedt SL. Beyond incontinence: the stigma of other urinary symptoms. J Adv Nurs 2010; 66: 2460-2470
10) Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, Coyne K, Kelleher C, Hampel C, Artibani W, Abrams P. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 2006; 50: 1306 -1315
11) Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167-178
12) 本間之夫,西沢理,山口脩.下部尿路機能に関する用語基準:国際禁制学会標準化部会報告.日排尿機能会誌2003; 14: 278-289
13) Coyne KS, Sexton CC, Thompson CL, Milsom I, Irwin D, Kopp ZS, Chapple CR, Kaplan S, Tubaro A, Aiyer LP, Wein AJ. The prevalence of lower urinary tract symptoms(LUTS)in the USA, the UK and Sweden: results from the Epidemiology of LUTS(EpiLUTS)study. BJU Int 2009; 104: 352-360
14) Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int 2008; 101: 1388-1395
15) Rosen RC, Coyne KS, Henry D, Link CL, Cinar A, Aiyer LP, Mollon P, Kaplan SA, Roehrborn CG, Thompson C. Beyond the cluster: methodological and clinical implications in the Boston Area Community Health survey and EPIC studies. BJU Int 2008; 101: 1274-1278
16) Irwin DE, Abrams P, Milsom I, Kopp Z, Reilly K on behalf of the EPIC Study Group. Understanding the elements of overactive bladder: questions raised by the EPIC study. BJU Int 2008; 101: 1381-1387
17) Irwin DE, Milsom I, Kopp Z, Abrams P, Artibani W, Herschorn S. Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder. Eur Urol 2009; 56: 14-20
18) Irwin DE, Kopp ZS, Agatep B, Milsom I, Abrams P. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int 2011; 108: 1132-1138
19) Lee YS, Lee KS, Jung JH, Han DH, Oh SJ, Seo JT, Lee JG, Park HS, Choo MS. Prevalence of overactive bladder, urinary incontinence, and lower urinary tract symptoms: results of Korean EPIC study. World J Urol 2011; 29: 185-190
20) Coyne KS, Wein AJ, Tubaro A, Sexton CC, Thompson CL, Kopp ZS, Aiyer LP. The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS. BJU Int 2009; 103(Suppl 3): 4-11
21) Sexton CC, Coyne KS, Kopp ZS, Irwin DE, Milsom I, Aiyer LP, Tubaro A, Chapple CR, Wein AJ on behalf of the EpiLUTS Team. The overlap of storage, voiding and postmicturition symptoms and implications for treatment seeking in the USA, UK and Sweden: EpiLUTS. BJU Int 2009; 103(Suppl 3): 12-23
22) Coyne KS, Kaplan SA, Chapple CR, Sexton CC, Kopp ZS, Bush EN, Aiyer LP on behalf of the EpiLUTS Team. Risk factors and comorbid conditions associated with lower urinary tract symptoms: EpiLUTS. BJU Int 2009; 103(Suppl 3): 24-32
23) Sexton CC, Coyne KS, Vats V, Kopp ZS, Irwin DE, Wagner TH. Impact of overactive bladder on work productivity in the United States: results from EpiLUTS. Am J Manag Care 2009; 15(4 Suppl): S98-S107
24) Coyne KS, Sexton CC, Vats V, Thompson C, Kopp ZS, Milsom I. National community prevalence of overactive bladder in the United States stratified by sex and age. Urology 2011; 77: 1081-1087
25) Ueda T, Tamaki M, Kageyama S, Yoshimura N, Yoshida O. Urinary incontinence among communitydwelling people aged 40 years or older in Japan: prevalence, risk factors, knowledge and self-perception. Int J Urol 2000; 7: 95-103
26) Araki I, Beppu M, Kajiwara M, Mikami Y, Zakoji H, Fukasawa M, Takeda M. Prevalence and impact on generic quality of life of urinary incontinence in Japanese working women: assessment by ICI questionnaire and SF-36 Health Survey. Urology 2005; 66: 88-93
27) 本間之夫,柿崎秀宏,後藤百万,武井実根雄,山西友典,林邦彦,排尿に関する疫学的研究委員会.排尿に関する疫学的研究.日排尿機能会誌2003; 14: 266-277
28) Homma Y, Yamaguchi O, Hayashi K, the Members of the Neurogenic Bladder Society Committee. An epidemiological survey of overactive bladder symptoms in Japan. BJU Int 2005; 96: 1314-1318
29) Homma Y, Yamaguchi O, Hayashi K, the Members of the Neurogenic Bladder Society Committee. Epidemiologic survey of lower urinary tract symptoms in Japan. Urology 2006; 68: 560-564
30) Hunskaar S, Burgio K, Clark A, Lapitan MC, Nelson R, Sillen U, Thom D. Epidemiology of urinary(UI)and faecal(FI)incontinence and pelvic organ prolapse(POP). In: Abrams P, Cardozo L, Khoury S, Wein A eds. Incontinence. Edition 2005. Volume 1. Plymouth, UK: Health Publications, 2005: 255-312
31) Hannestad YS, Rortveit G, Sandvik H, Hunskaar S. A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT Study. J Clin Epidemiol 2000; 53: 1150 -1157
32) Milsom I, Altman D, Lapitan MC, Nelson R, Sillen U, Thom D. Epidemiology of urinary(UI)and faecal(FI)incontinence and pelvic organ prolapse(POP). In: Abrams P, Cardozo L, Khoury S, Wein A eds. Incontinence. 4th Edition 2009. Volume 1. Plymouth, UK: Health Publications, 2009: 35-111
http://www.icud.info/PDFs/Incontinence.pdf
33) Handa VL, Garrett E, Hendrix S, Gold E, Robbins J. Progression and remission of pelvic organ prolapse: a longitudinal study of menopausal women. Am J Obstet Gynecol 2004; 190: 27-32
34) Bradley CS, Zimmerman MB, Qi Y, Nygaard IE for the Women’s Health Initiative(WHI). Natural history of pelvic organ prolapse in postmenopausal women. Obstet Gynecol 2007; 109: 848-854
35) Ponholzer A, Temml C, Wehrberger C, Marszalek M, Madersbacher S. The association between vascular risk factors and lower urinary tract symptoms in both sexes. Eur Urol 2006; 50: 581-586
36) Danforth KN, Townsend MK, Lifford K, Curhan GC, Resnick NM, Grodstein F. Risk factors for urinary incontinence among middle-aged women. Am J Obstet Gynecol 2006; 194: 339-345
37) Litman HJ, Steers WD, Wei JT, Kupelian V, Link CL, McKinlay JB for the Boston Area Community Health Survey Investigators. Relationship of lifestyle and clinical factors to lower urinary tract symptoms: results from Boston Area Community Health survey. Urology 2007; 70: 916-921
38) Tai HC, Chung SD, Ho CH, Tai TY, Yang WS, Tseng CH, Wu HP, Yu HJ. Metabolic syndrome components worsen lower urinary tract symptoms in women with type 2 diabetes. J Clin Endocrinol Metab 2010; 95: 1143 -1150
39) Uzun H, Zorba OU. Metabolic syndrome in female patients with overactive bladder. Urology 2012; 79: 72-75
40) Hannestad YS, Lie RT, Rortveit G, Hunskaar S. Familial risk of urinary incontinence in women: population based cross sectional study. BMJ 2004; 329: 889-891
41) Wennberg A-L, Altman D, Lundholm C, Klint A, Iliadou A, Peeker R, Fall M, Pedersen NL, Milsom I. Genetic influences are important for most but not all lower urinary tract symptoms: a populationbased survey in a cohort of adult Swedish twins. Eur Urol 2011; 59: 1032-1038
42) Persson J, Wolner-Hanssen P, Rydhstroem H. Obstetric risk factors for stress urinary incontinence: a population-based study. Obstet Gynecol 2000; 96: 440-445
43) Graham CA, Mallett VT. Race as a predictor of urinary incontinence and pelvic organ prolapse. Am J Obstet Gynecol 2001; 185: 116 -120
44) Hendrix SL, Clark A, Nygaard I, Aragaki A, Barnabei V, McTiernan A. Pelvic organ prolapse in the Women’s Health Initiative: gravity and gravidity. Am J Obstet Gynecol 2002; 186: 1160 -1166
45) Rortveit G, Daltveit AK, Hannestad YS, Hunskaar S for the Norwegian EPINCONT Study. Urinary incontinence after vaginal delivery or cesarean section. N Engl J Med 2003; 348: 900-907
46) Jackson RA, Vittinghoff E, Kanaya AM, Miles TP, Resnick HE, Kritchevsky SB, Simonsick EM, Brown JS for the Health, Aging, and Body Composition Study. Urinary incontinence in elderly women: findings from the Health, Aging, and Body Composition Study. Obstet Gynecol 2004; 104: 301-307
47) Rortveit G, Hunskaar S. Urinary incontinence and age at the first and last delivery: the Norwegian HUNT/EPINCONT study. Am J Obstet Gynecol 2006; 195: 433-438
48) Waetjen LE, Liao S, Johnson WO, Sampselle CM, Sternfield B, Harlow SD, Gold EB for the Study of Women’s Health Across the Nation. Factors associated with prevalent and incident urinary inconti nence in a cohort of midlife women: a longitudinal analysis of data: Study of Women’s Health Across the Nation. Am J Epidemiol 2007; 165: 309-318
49) Rortveit G, Brown JS, Thom DH, Van Den Eeden SK, Creasman JM, Subak LL. Symptomatic pelvic organ prolapse. Prevalence and risk factors in a population-based, racially diverse cohort. Obstet Gynecol 2007; 109: 1396-1403
50) Altman D, Falconer C, Cnattingius S, Granath F. Pelvic organ prolapse surgery following hysterectomy on benign indications. Am J Obstet Gynecol 2008; 198: 572.e1-572.e6
51) Apostolidis A, Kirana PS, Chiu G, Link C, Tsiouprou M, Hatzichristou D. Gender and age differences in the perception of bother and health care seeking for lower urinary tract symptoms: results from the hospitalised and outpatients’ profile and expectations study. Eur Urol 2009; 56: 937-947
52) Hermansen IL, O’Connell BO, Gaskin CJ. Women’s explanations for urinary incontinence, their management strategies, and their quality of life during the postpartum period. J Wound Ostomy Continence Nurs 2010; 37: 187-192
53) Nilsson M, Lalos A, Lalos O. The impact of female urinary incontinence and urgency on quality of life and partner relationship. Neurourol Urodyn 2009; 28: 976-981
54) Liao YM, Yang CY, Kao C, Dougherty MC, Lai YH, Chang Y, Chen HL, Chang LI. Prevalence and impact on quality of life of lower urinary tract symptoms among a sample of employed women in Taipei: a questionnaire survey. Int J Nurs Stud 2009; 46: 633-644
55) Yoshimura K, Oka Y, Kamoto T, Tsukamoto T, Oshiro K, Suzukamo Y, Kinukawa N, Ogawa O. Nighttime frequency, sleep disturbance and general health-related quality of life: is there a relation- Int J Urol 2009; 16: 96-100
56) Oh SJ, Choo MS, Kim HS, Kim JC, Lee JG, Yun JM, Kim DY, Paick JS, Lee JY, Chung BS, Min KS, Kim YH, Jung HC, Son H, Jeong JY, Rho J, Lee KS, Park WH, Ku JH. Generic and disease-specific health-related quality of life in women with coital incontinence: a prospective, multicenter study. Gynecol Obstet Invest 2008; 65: 62-67
57) Oh SJ, Ku JH, Choo MS, Yun JM, Kim DY, Park WH. Health-related quality of life and sexual function in women with stress urinary incontinence and overactive bladder. Int J Urol 2008; 15: 62-67
58) van Brummen HJ, Bruinse HW, van de Pol G, Heintz APM, van der Vaart CH. Bothersome lower urinary tract symptoms 1 year after first delivery: prevalence and the effect of childbirth. BJU Int 2006; 98: 89-95
59) Kim YH, Seo JT, Yoon H. The effect of overactive bladder syndrome on the sexual quality of life in Korean young and middle aged women. Int J Impot Res 2005; 17: 158-163
60) Fultz NH, Burgio K, Diokno AC, Kinchen KS, Obenchain R, Bump RC. Burden of stress urinary incontinence for community-dwelling women. Am J Obstet Gynecol 2003; 189: 1275-1282
61) Bradway C. Urinary incontinence among older women. Measurement of the effect on health-related quality of life. J Gerontol Nurs 2003; 29: 13-19
62) Okamura K, Usami T, Nagahama K, Maruyama S, Mizuta E. The relationships among filling, voiding subscores from International Prostate Symptom Score and quality of life in Japanese elderly men and women. Eur Urol 2002; 42: 498-505
63) Okamura K, Usami T, Nagahama K, Maruyama S, Mizuta E. “Quality of life”assessment of urination in elderly Japanese men and women with some medical problems using International Prostate Symptom Score and King’s Health Questionnaire. Eur Urol 2002; 41: 411-419
64) Coyne KS, Margolis MK, Brewster-Jordan J, Sutherland SE, Bavendam T, Rogers RG. Evaluating the impact of overactive bladder on sexual health in women: what is relevant-J Sex Med 2007; 4: 124-136
65) Fritel X, Varnoux N, Zins M, Breart G, Ringa V. Symptomatic pelvic organ prolapse at midlife, quality of life, and risk factors. Obstet Gynecol 2009; 113: 609-616
66) Matsuyama H, Tomimatsu T, Tatsumura M, Sugino N, Naito K. Surgical repair of pelvic-floor prolapse: lessons learned from longitudinal follow-up of quality-of-life survey. Aktuelle Urol 2010; 41: S30 -S33
67) FitzGerald MP, Janz NK, Wren PA, Wei JT, Weber AM, Ghetti C, Cundiff GW for the Pelvic Floor Disorders Network. Prolapse severity, symptoms and impact on quality of life among women planning sacrocolpopexy. Int J Gynaecol Obstet 2007; 98: 24-28
68) Digesu GA, Chaliha C, Salvatore S, Hutchings A, Khullar V. The relationship of vaginal prolapse severity to symptoms and quality of life. BJOG: Int J Obstet Gynaecol 2005; 112: 971-976
69) Lee KS, Lee YS, Seo JT, Na YG, Choo MS, Kim JC, Seo JH, Yoon JM, Lee JG, Kim DY, Yoo ES, Min KS, Hong JY, Lee JZ. A prospective multicenter randomized comparative study between the U-and H-type methods of the TVT SECUR procedure for the treatment of female stress urinary incontinence: 1-year follow-up. Eur Urol 2010; 57: 973-979
70) Guerrero KL, Emery SJ, Wareham K, Ismail S, Watkins A, Lucas MG. A randomised controlled trial comparing TVTTM, PelvicolTM and autologous fascial slings for the treatment of stress urinary incontinence in women. BJOG: Int J Obstet Gynaecol 2010; 117: 1493-1503
71) Jha S, Radley S, Farkas A, Jones G. The impact of TVT on sexual function. Int Urogynecol J Pelvic Floor Dysfunct 2009; 20: 165-169
72) Murphy M, van Raalte H, Mercurio E, Haff R, Wiseman B, Lucente VR. Incontinence-related quality of life and sexual function following the tension-free vaginal tape versus the“inside-out”tension-free vaginal tape obturator. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19: 481-487
73) Apostolidis A, Gonzales GE, Fowler CJ. Effect of intravesical resiniferatoxin(RTX)on lower urinary tract symptoms, urodynamic parameters, and quality of life of patients with urodynamic increased bladder sensation. Eur Urol 2006; 50: 1299-1305
74) Kalsi V, Apostolidis A, Popat R, Gonzales G, Fowler CJ, Dasgupta P. Quality of life changes in patients with neurogenic versus idiopathic detrusor overactivity after intradetrusor injections of botulinum neurotoxin type A and correlations with lower urinary tract symptoms and urodynamic changes. Eur Urol 2006; 49: 528-535
75) Ko PC, Lo TS, Tseng LH, Lin YH, Liang CC, Lee SJ. Use of a pessary in treatment of pelvic organ prolapse: quality of life, compliance, and failure at 1-year follow-up. J Minim Invasive Gynecol 2011; 18: 68-74
76) Caruso S, Bandiera S, Cavallaro A, Cianci S, Vitale SG, Rugolo S. Quality of life and sexual changes after double transobturator tension-free approach to treat severe cystocele. Eur J Obstet Gynecol Reprod Biol 2010; 151: 106-109
77) Su TH, Lau HH, Huang WC, Chen SS, Lin TY, Hsieh CH, Yeh CY. Short term impact on female sexual function of pelvic floor reconstruction with the Prolift procedure. J Sex Med 2009; 6: 3201-3207 78) Thomas AZ, Giri SK, Cox A-M, Creagh T. Long-term quality-of-life outcome after mesh sacrocolpopexy for vaginal vault prolapse. BJU Int 2009; 104: 1676-1679
78) Thomas AZ, Giri SK, Cox A-M, Creagh T. Long-term quality-of-life outcome after mesh sacrocolpopexy for vaginal vault prolapse. BJU Int 2009; 104: 1676-1679
79) 大日方大亮,長谷川了,井門祐一郎,吉澤剛,武信康弘,咲間隆裕,松井強,佐藤克彦,持田淳一,杉本周路,一瀬岳人,平野大作,吉田利夫,高橋悟.骨盤臓器脱に対するTransvaginal Mesh(TVM)の効果─ 術前後のQOL を含めて─.日女性骨盤底医会誌2008; 5: 110 -111
80) Murphy M, Sternschuss G, Haff R, van Raalte H, Saltz S, Lucente V. Quality of life and surgical satisfaction after vaginal reconstructive vs obliterative surgery for the treatment of advanced pelvic organ prolapse. Am J Obstet Gynecol 2008; 198: 573.e1-573.e7
81) 福本由美子,上阪裕香,山本圭介,伊藤伸一郎,山中幹基,竹山政美,野間雅倫.性器脱手術患者のQuality of Life(QOL)評価の試み.日泌尿会誌2008; 99: 531-542
82) Fayyad AM, Redhead E, Awan N, Kyrgiou K, Prashar S, Hill SR. Symptomatic and quality of life outcomes after site-specific fascial reattachment for pelvic organ prolapse repair. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19: 191-197
83) Hullfish KL, Bovbjerg VE, Steers WD. Colpocleisis for pelvic organ prolapse. Obstet Gynecol 2007; 110: 341-345
84) Barber MD, Amundsen CL, Paraiso MFR, Weidner AC, Romero A, Walters MD. Quality of life after surgery for genital prolapse in elderly women: obliterative and reconstructive surgery. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18: 799-806
85) Altman D, Lopez A, Gustafsson C, Falconer C, Nordenstam J, Zetterstrom J. Anatomical outcome and quality of life following posterior vaginal wall prolapse repair using collagen xenograft. Int Urogynecol J Pelvic Floor Dysfunct 2005; 16: 298-303
86) Wren PA, Janz NK, Brubaker L, Fitzgerald MP, Weber AM, LaPorte FB, Wei JT for the Pelvic Floor Disorders Network. Reliability of health-related quality-of-life measures 1 year after surgical procedures for pelvic floor disorders. Am J Obstet Gynecol 2005; 192: 780-788
87) Srikrishna S, Robinson D, Cardozo L, Gonzalez J. Is there a discrepancy between patient and physician quality of life assessment-Neurourol Urodyn 2009; 28: 179-182
88) Srikrishna S, Robinson D, Cardozo L, Gonzalez J. Is there a difference in patient and physician quality of life evaluation in pelvic organ prolapse-Int Urogynecol J Pelvic Floor Dysfunct 2008; 19: 517-520
89) Oh SJ, Ku JH. Comparison of three disease-specific quality-of-life questionnaires(Bristol Female Lower Urinary Tract Symptoms, Incontinence Quality of Life and King’s Health Questionnaire)in women with stress urinary incontinence. Scand J Urol Nephrol 2007; 41: 66-71
90) Reid FM, Smith ARB, Dunn G. Which questionnaire-A psychometric evaluation of three patient-based outcome measures used to assess surgery for stress urinary incontinence. Neurourol Urodyn 2007; 26: 123-128
91) Artibani W, Pesce F, Prezioso D, Scarpa RM, Zattoni F, Tubaro A, Rizzi CA, Santini AM, Simoni L, the FLOW study group. Italian validation of the urogenital distress inventory and its application in LUTS patients. Eur Urol 2006; 50: 1323-1329
92) Tubaro A, Zattoni F, Prezioso D, Scarpa RM, Pesce F, Rizzi CA, Santini AM, Simoni L, Artibani W, the FLOW study group. Italian validation of the International Consultation on Incontinence Questionnaires. BJU Int 2006; 97: 101-108
93) Scarpero HM, Fiske J, Xue X, Nitti VW. American Urological Association Symptom Index for lower urinary tract symptoms in women: correlation with degree of bother and impact on quality of life. Urology 2003; 61: 1118 -1122
94) Quek KF, Chua CB, Low WY, Razack AH, Loh CS. Reliability and validity of the Malay version of the health-related quality of life instrument in a Malaysian population. BJU Int 2002; 90: 37-40
95) Teleman P, Stenzelius K, Iorizzo L, Jakobsson U. Validation of the Swedish short forms of the Pelvic Floor Impact Questionnaire(PFIQ-7), Pelvic Floor Distress Inventory(PFDI-20)and Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire(PISQ-12). Acta Obstet Gynecol Scand 2011; 90: 483-487
96) Peterson TV, Karp DR, Aguilar VC, Davila GW. Validation of a global pelvic floor symptom bother questionnaire. Int Urogynecol J 2010; 21: 1129-1135
97) Banerjee C, Banerjee M, Hatzmann W, Schiermeier S, Sachse K, Hellmich M, Noe GK. The German version of the‘ICIQ Vaginal Symptoms questionnaire’(German ICIQ-VS): an instrument validation study. Urol Int 2010; 85: 70-79
98) Manchana T, Bunyavejchevin S. Validation of the Prolapse Quality of Life(P-QOL)questionnaire in Thai version. Int Urogynecol J 2010; 21: 985-993
99) Claerhout F, Moons P, Ghesquiere S, Verguts J, De Ridder D, Deprest J. Validity, reliability and responsiveness of a Dutch version of the prolapse quality-of-life(P-QoL)questionnaire. Int Urogynecol J 2010; 21: 569-578
100) Srikrishna S, Robinson D, Cardozo L. Validation of the Patient Global Impression of Improvement(PGI-I)for urogenital prolapse. Int Urogynecol J 2010; 21: 523-528
101) Svihrova V, Digesu GA, Svihra J, Hudeckova H, Kliment J, Swift S. Validation of the Slovakian version of the P-QOL questionnaire. Int Urogynecol J 2010; 21: 53-61
102) de Oliveira MS, Tamanini JTN, de Aguiar Cavalcanti G. Validation of the Prolapse Quality-of-Life Questionnaire(P-QoL)in Portuguese version in Brazilian women. Int Urogynecol J Pelvic Floor Dysfunct 2009; 20: 1191-1202
103) Rogers RG, Rockwood T, Thakar R, PISQ IR Working Group. A revised measure of sexual function in women with pelvic floor disorders(PFD); the Pelvic Organ Prolapse Incontinence Sexual Questionnaire, IUGA-Revised(PISQ IR). Int Urogynecol J 2012; 23(Suppl 2): S152-S153
104) Tamanini JTN, Almeida FG, Girotti ME, Riccetto CLZ, Palma PCR, Rios LAS. The Portuguese validation of the International Consultation on Incontinence Questionnaire-Vaginal Symptoms(ICIQ-VS)for Brazilian women with pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19: 1385-1391
105) Cam C, Sakalli M, Ay P, Aran T, Cam M, Karateke A. Validation of the prolapse quality of life questionnaire(P-QOL)in a Turkish population. Eur J Obstet Gynecol Reprod Biol 2007; 135: 132-135
106) Price N, Jackson SR, Avery K, Brookes ST, Abrams P. Development and psychometric evaluation of the ICIQ Vaginal Symptoms Questionnaire: the ICIQ-VS. BJOG: Int J Obstet Gynaecol 2006; 113: 700-712
107) Barber MD, Walters MD, Cundiff GW, the PESSRI Trial Group. Responsiveness of the Pelvic Floor Distress Inventory(PFDI)and Pelvic Floor Impact Questionnaire(PFIQ)in women undergoing vaginal surgery and pessary treatment for pelvic organ prolapse. Am J Obstet Gynecol 2006; 194: 1492-1498
108) Rogers RG, Coates KW, Kammerer-Doak D, Khalsa S, Qualls C. A short form of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire(PISQ-12). Int Urogynecol J Pelvic Floor Dysfunct 2003; 14: 164-168
109) Digesu GA, Santamato S, Khullar V, Santillo V, Digesu A, Cormio G, Loverro G, Selvaggi L. Validation of an Italian version of the prolapse quality of life questionnaire. Eur J Obstet Gynecol Reprod Biol 2003; 106: 184-192
110) Homma Y, Yoshida M, Yamanishi T, Gotoh M. Core Lower Urinary Tract Symptom Score(CLSS)questionnaire: a reliable tool in the overall assessment of lower urinary tract symptoms. Int J Urol 2008; 15: 816-820
111) Fujimura T, Kume H, Nishimatsu H, Sugihara T, Nomiya A, Tsurumaki Y, Miyazaki H, Suzuki M, Fukuhara H, Enomoto Y, Homma Y. Assessment of lower urinary tract symptoms in men by international prostate symptom score and core lower urinary tract symptom score. BJU Int 2012; 109: 1512-1516
112) 日本排尿機能学会男性下部尿路症状診療ガイドライン作成委員会編.男性下部尿路症状診療ガイドライン.ブラックウェルパブリッシング,2008
113) 後藤百万,Donovan J,Corcos J,Badia X,Kelleher CJ,Naughton M,Shaw C,Avery K,本間之夫.尿失禁の症状・QOL 質問票:スコア化ICIQ-SF (International Consultation on Incontinence-Questionnaire: Short Form).日神因性膀胱会誌2001; 12: 227-231
114) Gotoh M, Homma Y, Funahashi Y, Matsukawa Y, Kato M. Psychometric validation of the Japanese version of the International Consultation on Incontinence Questionnaire-Short Form. Int J Urol 2009; 16: 303-306
115) Uemura S, Homma Y. Reliability and validity of King’s Health Questionnaire in patients with symptoms of overactive bladder with urge incontinence in Japan. Neurourol Urodyn 2004; 23: 94-100
116) Okamura K, Nojiri Y, Osuga Y. Reliability and validity of the King’s Health Questionnaire for lower urinary tract symptoms in both genders. BJU Int 2009; 103: 1673-1678
117) 本間之夫,後藤百万.Overactive bladder questionnaire(OAB-q)の日本語版の作成と言語的妥当性の検討.日排尿機能会誌2006; 17: 241-249
118) 本間之夫,後藤百万,横山修,西澤理,山西友典,武井実根雄,吉田正貴,武田正之,柿崎秀宏,山口脩.Overactive bladder questionnaire(OAB-q)の日本語版の計量心理学的検討.日排尿機能会誌2006; 17: 250-256
119) 池田俊也,小林美亜,清水隆明,吉田正貴,後藤百万,本間之夫,山口脩.Nocturia Quality of Life Questionnaire(N-QOL)日本語版の計量心理学的検討.日排尿機能会誌2009; 20: 325-331
120) 本間之夫,安藤高志,吉田正貴,武井実根雄,後藤百万,大川麻子,影山慎二,福原俊一.尿失禁QOL 質問票日本語版の妥当性の検討.日排尿機能会誌2002; 13: 247-257


 

 
ページトップへ

ガイドライン解説

close-ico
カテゴリで探す
五十音で探す

診療ガイドライン検索

close-ico
カテゴリで探す
五十音で探す